Zobrazeno 1 - 10
of 2 820
pro vyhledávání: '"adult T-cell leukemia lymphoma"'
Publikováno v:
JAAD Case Reports, Vol 55, Iss , Pp 10-12 (2025)
Externí odkaz:
https://doaj.org/article/d67ad97df1ca4b3cbf0ac041dc00daf3
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 851-854 (2024)
Abstract A 79‐year‐old man presented with respiratory distress associated with a mediastinal mass and pleural effusion, and was diagnosed as having adult T‐cell leukemia/lymphoma. The patient was highly refractory to anticancer drugs and radiot
Externí odkaz:
https://doaj.org/article/ca0569c21fa2473ea839ed05b9925112
Autor:
Satoshi Inaba, Masataka Kudo, Hironori Kamano, Yoshihiro Ohishi, Junichi Kiyasu, Takashi Watari
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-7 (2024)
Abstract Background Primary central nervous system lymphoma is rare, and primary central nervous system T cell lymphoma is relatively uncommon, contributing to
Externí odkaz:
https://doaj.org/article/da66caa6f53348ba832dd8db907a2067
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 602-607 (2024)
Introduction: CC chemokine receptor 4 (CCR4), which is involved in leukocyte migration, is expressed in most tumor cells in patients with adult T-cell leukemia/lymphoma (ATLL). Case Presentation: Here we report the case of a 78-year-old man diagnosed
Externí odkaz:
https://doaj.org/article/4478b1b60e744b6c8f560f69e2c86b7f
Autor:
A.L. Bittencourt, L. Farre
Publikováno v:
International Journal of Infectious Diseases, Vol 145, Iss , Pp 107058- (2024)
Infective dermatitis associated with human T-cell lymphotropic virus type-1 (HTLV-1) (IDH) is a severe form of chronically infected eczema occurring in early childhood, although very rarely cases have been reported in adults. Most of the cases are fr
Externí odkaz:
https://doaj.org/article/a69d224a3eda4d6487caeb79bd40337d
Autor:
Alexandra Ionete, Alexandru Bardas, Zsofia Varady, Madalina Vasilica, Orsolya Szegedi, Daniel Coriu
Publikováno v:
Diseases, Vol 12, Iss 9, p 210 (2024)
Adult T-cell Leukemia/Lymphoma (ATLL) is a rare but aggressive malignancy associated with the human T-cell lymphotropic virus type 1 (HTLV-1). ATLL is a challenging malignancy characterized by its aggressive nature and poor prognosis. Despite advance
Externí odkaz:
https://doaj.org/article/bf7cdfe4e45a408da2b06b1a0b7d685f
Autor:
Reiji Muto, Hiroaki Miyoshi, Kazutaka Nakashima, Mai Takeuchi, Makoto Hamasaki, Koichi Ohshima
Publikováno v:
Cancer Medicine, Vol 13, Iss 6, Pp n/a-n/a (2024)
Abstract Aims T‐follicular helper (TFH) cells are effector T‐cells that are crucial for B‐cell selection and differentiation. T‐cell lymphomas derived from TFH cells have distinct characteristics. Additionally, in the World Health Organizatio
Externí odkaz:
https://doaj.org/article/229c9be895644da5b37014378a78e88c
Publikováno v:
BMC Research Notes, Vol 16, Iss 1, Pp 1-7 (2023)
Abstract Objectives Human lymphotropic virus type 1 (HTLV-1) is the cause of two major diseases, ATLL and HAM/TSP in a percentage of carriers. Despite progress in understanding the pathogenesis of these two diseases, the exact pathogenesis mechanism
Externí odkaz:
https://doaj.org/article/890a680cbae248a2a7f40875a9cb4baa
Autor:
Abdulrasheed Usman, Muhammad Hamis Musa, Bukhari Isah Shuaib, Olayemi Balogun, Mukhtar Adeiza
Publikováno v:
Clinical and Experimental Pediatrics, Vol 66, Iss 7, Pp 307-316 (2023)
Background The peripartum period is both a highly vulnerable stage and a significant indicator of a population’s health status. Interest is increasing in human T-cell lymphotropic virus type-1 (HTLV-1) transmission due to its adverse health impacts
Externí odkaz:
https://doaj.org/article/c21cd254992948529e4e09df08b1e57f
Autor:
Arman Shafiee, Niloofar Seighali, Nooshin Taherzadeh-ghahfarokhi, Shayan Mardi, Sorour Shojaeian, Shahrzad Shadabi, Mahsa Hasani, Sabahat Haghi, Sayed-Hamidreza Mozhgani
Publikováno v:
Virology Journal, Vol 20, Iss 1, Pp 1-13 (2023)
Abstract Background ATLL (Adult T-Cell Leukemia/Lymphoma) is an aggressive hematological malignancy. This T-cell non-Hodgkin lymphoma, caused by the human T-cell leukemia virus type 1 (HTLV-1), is challenging to treat. There is no known treatment for
Externí odkaz:
https://doaj.org/article/4a6ae2d6d4d841c5adea8deff7ac7c17